Shiv Nadar & Sanjay Kalra Associates is an investment firm which leverages operating expertise and proprietary capital to fuel growth in transitional markets. SNSK aims to acquire technology products and platforms which are either disrupting or being disrupted by regulatory changes, evolving consumer attitudes, changing demographics and emerging technologies.
SNSK’s initial focus is the U.S. Healthcare IT ecosystem. The firm will invest up to USD 500 million to buy-out or carve-out IT products and platforms across Providers, Payers, Pharma and Life Sciences.
The U.S. healthcare industry is undergoing radical transformation with the Affordable Care Act. Evolving thoughts and business models have little semblance to present mechanisms. Over the next five years SNSK aspires to be an engine accelerating digital solutions to make patient care more accountable, efficient, predictable and effective.
The focus areas include Hospitals, Ambulatory, Long Term Acute Care, Physicians, Information Exchanges, ACOs, Self-funded Insurers, Commercial Insurers and Insurance Exchanges. IT products and platforms for Customer Engagement, Clinical Management, RCM, SCM, Sales & Marketing, Care & Wellness, Analytics and Population Health are of specific interest.
In Pharma & Life Sciences, the firm will invest in IT product and platform opportunities in Drug Development, Clinical Trials and Pharmacovigilance.
SNSK’s investment thesis favors creating an integrated portfolio of mature businesses. The firm will also invest in select early stage U.S. and Indian companies, where the product, platform or talent will accelerate portfolio objectives.
The firm intends to realize synergies across its portfolio and rigorously explore growth in new markets. SNSK’s operational expertise, cost discipline, India based R&D capability and cutting-edge technology adoption will support businesses in achieving their potential.
SNSK’s investment horizon is medium-term, giving entrepreneurial management teams sufficient time to unlock the value of integrated components.
As an entrepreneur and the founder of HCL, Shiv Nadar has created institutions of impact in technology, education, healthcare and philanthropy. Sanjay Kalra has built businesses by acquiring and transforming companies, creating joint ventures, nurturing startups and engineering teams. The founders have successfully built and operated technology businesses with an aggregate enterprise value exceeding USD 25 billion. They will bring the same entrepreneurial agility and passion to support the SNSK portfolio.